Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
OBSERVATIONAL
2012-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Clinical and Genetic Analysis of ROP
NCT04420156
European Disease Registry on Retinopathy of Prematurity (ROP)
NCT04939571
Cryotherapy for Retinopathy of Prematurity (CRYO-ROP) - Outcome Study of Cryotherapy for Retinopathy of Prematurity
NCT00000133
The Early Treatment for Retinopathy of Prematurity Study (ETROP)
NCT00027222
Investigation of Neurovascular Coupling in Glaucoma Patients and Healthy Subjects
NCT03870230
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
ROP infants treated with intravitreal anti-VEGF agents
No interventions assigned to this group
ROP infants treated with retinal laser photocoagulation
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital Freiburg
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Andreas Stahl, MD
MD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Andreas Stahl, MD
Role: PRINCIPAL_INVESTIGATOR
University Eye Hospital Freiburg, Germany
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Eye Hospital
Freiburg im Breisgau, Baden-Wurttemberg, Germany
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
University Eye Hospital Freiburg, Germany
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
VISOR Study
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.